Related Experiment Video

Updated: May 2, 2026

Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue
10:28

Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue

Published on: July 17, 2018

11.7K

Adipocytokine concentrations in children with different types of beta-thalassemia

Yaşar Enli1, Yasemin I Balci, Cafer Gönen

  • 1Department of Medical Biochemistry, Pamukkale University, Faculty of Medicine , Denizli , Turkey.

Scandinavian Journal of Clinical and Laboratory Investigation
|February 26, 2014
PubMed

Insights

Adipocytokine levels (adiponectin, resistin, visfatin) are elevated in beta-thalassemia patients, particularly in more severe forms (major and intermedia), suggesting a role in disease complications.

Area of Science:

  • Endocrinology
  • Hematology
  • Metabolic Research

Background:

  • Beta-thalassemia is an inherited blood disorder characterized by impaired beta-globin chain production.
  • Inflammatory processes and adipocytokines from adipose tissue may contribute to thalassemia complications.
  • Key adipocytokines include adiponectin, resistin, and visfatin.

Purpose of the Study:

  • To analyze serum concentrations of adiponectin, resistin, and visfatin in different types of beta-thalassemia.
  • To investigate potential correlations between adipocytokine levels and beta-thalassemia disease severity.

Main Methods:

  • Serum adipocytokine levels were measured in 30 healthy children (controls), 30 beta-thalassemia minor patients, 17 beta-thalassemia intermedia patients, and 29 beta-thalassemia major patients.
  • Measurements included anthropometric data, complete blood count, and biochemical parameters.

Main Results:

  • Resistin and visfatin were higher in beta-thalassemia minor patients compared to controls.
  • Adiponectin, resistin, and visfatin were significantly elevated in beta-thalassemia intermedia and major patients versus controls.
  • Intermedia and major thalassemia patients showed higher adipocytokine levels than minor thalassemia patients, with no significant difference between major and intermedia forms.

Conclusions:

  • Elevated adipocytokine levels in beta-thalassemia patients suggest their potential involvement in disease pathogenesis and complications.
  • Further research is warranted to elucidate the specific roles of adiponectin, resistin, and visfatin in beta-thalassemia.
Abstract

Keywords:
Beta-thalassemiaadipocytokineadiponectinresistinvisfatin

More Related Videos

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

6.8K
Differentiation and Imaging of Brown Adipocytes from the Stromal Vascular Fraction of Interscapular Adipose Tissue from Newborn Mice04:46

Differentiation and Imaging of Brown Adipocytes from the Stromal Vascular Fraction of Interscapular Adipose Tissue from Newborn Mice

Published on: February 3, 2023

2.3K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
32.7K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.9K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81